DCAT WEEK '17
Novasep: Greenfield facility ready for operations
Novasep’s greenfield facility was constructed in 20 months and combines R&D service, QC, and scale-up laboratories.
At the forum, Kevin Daley, Director, Pharmaceuticals at Novasep explained the €11m ($11.81m) investment supports the company’s differentiated technologies for small molecule APIs and biopharmaceuticals.
The facility features GMP production suites with capacity to support clinical trials through validation and commercial production.
Daley said Novasep is actively looking for a partner for fill and finish and it is “near” making an announcement.
The facility was inaugurated on the 23rd of February. “We’re now ready for operations,” said Daley.
